GC
EBS icon

Globeflex Capital’s Emergent Biosolutions EBS Stock Holding History

Globeflex Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Hold
241,298
– – 0.3% 93
2025
Q4 		$2.98M Hold
241,298
– – 0.46% 73
2025
Q3 		$2.13M Buy
+241,298
New +$1.88M 0.33% 88
2021
Q3 		– Sell
-5,878
Closed -$370K – 467
2021
Q2 		$370K Sell
5,878
-9,580
-62% -$615K 0.07% 315
2021
Q1 		$1.44M Sell
15,458
-1,460
-9% -$150K 0.26% 122
2020
Q4 		$1.52M Buy
16,918
+159
+0.9% +$14.6K 0.32% 86
2020
Q3 		$1.73M Sell
16,759
-4,281
-20% -$461K 0.46% 50
2020
Q2 		$1.66M Sell
21,040
-178
-0.8% -$13.3K 0.42% 49
2020
Q1 		$1.23M Sell
21,218
-2,355
-10% -$136K 0.38% 69
2019
Q4 		$1.27M Hold
23,573
– – 0.24% 138
2019
Q3 		$1.23M Hold
23,573
– – 0.27% 113
2019
Q2 		$1.14M Sell
23,573
-27
-0.1% -$1.29K 0.24% 127
2019
Q1 		$1.19M Hold
23,600
– – 0.25% 123
2018
Q4 		$1.4M Buy
23,600
+2
+0% +$129 0.33% 92
2018
Q3 		$1.55M Sell
23,598
-396
-2% -$23.1K 0.31% 97
2018
Q2 		$1.21M Sell
23,994
-3,898
-14% -$203K 0.25% 141
2018
Q1 		$1.47M Buy
27,892
+20,968
+303% +$1.05M 0.31% 108
2017
Q4 		$322K Buy
+6,924
New +$291K 0.09% 272
2015
Q4 		– Sell
-27,125
Closed -$773K – 461
2015
Q3 		$773K Buy
+27,125
New +$894K 0.17% 223
2015
Q2 		– Sell
-89,151
Closed -$2.56M – 530
2015
Q1 		$2.56M Sell
89,151
-4,840
-5% -$139K 0.49% 42
2014
Q4 		$2.56M Sell
93,991
-25
-0% -$596 0.49% 46
2014
Q3 		$2M Sell
94,016
-3,769
-4% -$86.3K 0.23% 136
2014
Q2 		$2.2M Sell
97,785
-41
-0% -$955 0.24% 131
2014
Q1 		$2.47M Buy
97,826
+31,520
+48% +$796K 0.28% 120
2013
Q4 		$1.52M Sell
66,306
-5,425
-8% -$113K 0.18% 145
2013
Q3 		$1.37M Hold
71,731
– – 0.18% 163
2013
Q2 		$1.03M Buy
+71,731
New +$1.04M 0.14% 186

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Globeflex Capital's EBS Position: Q1 2026 in Review

Globeflex Capital held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 241,298 shares worth $2M. The position accounts for 0.3% of the portfolio, ranked #93.

Globeflex Capital first reported a position in EBS in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.98M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Globeflex Capital held 241,298 shares of Emergent Biosolutions worth $2M as of Q1 2026.
  • Globeflex Capital left its Emergent Biosolutions share count unchanged in Q1 2026.
  • Emergent Biosolutions made up 0.3% of Globeflex Capital's portfolio in Q1 2026, its #93 holding.
  • Globeflex Capital first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 27 quarters since.
  • Globeflex Capital's Emergent Biosolutions position peaked at $2.98M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.